ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Neurology

Top Neurology Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LORN MILLER MD

Neurology

21,390

$2.04M

698
148 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

78%
patients receiving schedule three controlled substances

Avg: 9%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$96
Average prescription price

Avg: $175

CHRISTOPHER LAGANKE MD

Neurology

15,243

$5.46M

803
283 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 24%

$358
Average prescription price

Avg: $175

PAMELA QUINN M.D.

Neurology

9,155

$1.13M

568
358 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$123
Average prescription price

Avg: $175

WAEL HAMO M.D.

Neurology

8,307

$790K

727
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

37%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 24%

$95
Average prescription price

Avg: $175

SHERI SWADER M.D.

Neurology

7,438

$826K

634
409 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $175

DIANE COUNCE MD

Neurology

7,300

$996K

563
320 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $175

SADIK YESIL MD

Neurology

6,763

$661K

578
187 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

43%
patients receiving schedule three controlled substances

Avg: 9%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 24%

$98
Average prescription price

Avg: $175

RICHARD DIETHELM M.D.

Neurology

6,716

$1.04M

733
497 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$155
Average prescription price

Avg: $175

RASSAN TARABEIN M.D.

Neurology

6,653

$479K

294
58 are 65+

69%
patients receiving schedule two controlled substances

Avg: 4%

41%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $175

ANJANEYULU ALAPATI M.D.

Neurology

6,124

$888K

598
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 9%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$145
Average prescription price

Avg: $175

LARRY EPPERSON MD

Neurology

6,077

$1.2M

733
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$198
Average prescription price

Avg: $175

ANTHONY ESPOSITO MD

Neurology

5,799

$1.14M

492
248 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$197
Average prescription price

Avg: $175

HASSAN KESSERWANI MD

Neurology

5,782

$1.37M

722
378 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$237
Average prescription price

Avg: $175

GEORGE MORGAN MD

Neurology

5,159

$971K

371
230 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$188
Average prescription price

Avg: $175

CHARLES MARKLE M.D.

Neurology

5,037

$631K

451
302 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$125
Average prescription price

Avg: $175

SCOTT HITCHCOCK D.O.

Neurology

4,897

$1.08M

357
196 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 24%

$221
Average prescription price

Avg: $175

OZGUR OZTAS M.D.

Neurology

4,747

$686K

479
318 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$145
Average prescription price

Avg: $175

FRITZ LACOUR M.D.

Neurology

4,305

$687K

346
242 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$160
Average prescription price

Avg: $175

FAZAL RAHIM M.D.

Neurology

4,245

$1.29M

444
180 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$303
Average prescription price

Avg: $175

RICHARD HULL MD

Neurology

4,238

$786K

361
245 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$186
Average prescription price

Avg: $175

CLEMMIE PALMER M.D.

Neurology

4,119

$614K

236
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $175

ILYAS SHAIKH MD

Neurology

4,018

$325K

170
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $175

DANIEL POTTS M.D.

Neurology

4,013

$803K

376
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$200
Average prescription price

Avg: $175

SHER GHORI MD

Neurology

3,523

$796K

397
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 24%

$226
Average prescription price

Avg: $175

HAMP GREENE MD

Neurology

3,476

$679K

298
150 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 24%

$195
Average prescription price

Avg: $175

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank